Evaluation of adjuvant therapy for lung cancer surgery
Hashimoto, K.; Akahagi, E.; Saito, Y.; Sato, H.; Suda, H.
Nihon Kyobu Geka Gakkai 26(3): 330-331
1978
ISSN/ISBN: 0369-4739 PMID: 701883 Document Number: 126539
Document emailed within 1 workday
Related Documents
Funatsu, H. 1978: Surgery and adjuvant therapy of lung cancer--with special reference to indications and effects of radiotherapy Nihon Kyobu Geka Gakkai 26(3): 331-334Yamaguchi, M.; Fukuyama, Y.; Ichinose, Y. 2003: Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 203-208
Joss, R.A.; Brand, B. 1990: Adjuvant therapy of lung cancer Helvetica Chirurgica Acta 56(5): 735-747
Muggia, F.M.; McGuire, W.P. 1978: Adjuvant systemic therapy of lung cancer Cancer Clinical Trials 1(3): 235-241
Ferguson, M.K.; Little, A.G.; Golomb, H.M.; Hoffman, P.C.; DeMeester, T.R.; Beveridge, R.; Skinner, D.B. 1986: The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer Journal of Thoracic and Cardiovascular Surgery 91(3): 344-349
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Miyazawa, N.; Tsuchiya, R.; Naruke, T.; Yoneyama, T.; Suemasu, K. 1985: BCG immunotherapy as an adjuvant to surgery in lung cancer. An analysis of lymphocyte subsets of the peripheral blood using monoclonal antibodies Nihon Kyobu Shikkan Gakkai Zasshi 23(1): 56-61
Movsas, B. 2001: Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer Oncology 15(12): 1549-1558
Dent, D.M.; Hacking, E.A.; Gudgeon, C.A. 1989: Adjuvant therapy after surgery for breast cancer--should women without axillary node involvement be candidates South African Medical Journal 75(11): 513-514
Syrigos, K.N.; Konstantinou, M.; Sepsas, E.; Papamichales, G.; Loullias, A.; Belenis, I.; Skottis, I.; Charpidou, A.; Roussos, C. 2007: Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study Anticancer Research 27(4c): 2887-2892
Overgaard, M. 2000: Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy Rays 25(3): 325-330
Bahena, J.; Labastida Almendaro, S.; Ayala Hernández, J.R.; Fernández Orozco, A. 1998: Impact of the interval between surgery and radiotherapy in the initial phases of breast cancer in patients who did not receive systemic adjuvant therapy Ginecologia y Obstetricia de Mexico 66: 87-91
Suzuki, N.; Suzuki, S.; Tominaga, K.; Hoshino, M.; Naruse, H.; Fukushima, M.; Murakami, M. 2012: A case report of recurrent lung metastasis after surgery for rectal cancer for which lung radiofrequency ablation therapy and long-term administration of FOLFIRI were effective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2267-2269
Rosenberg, S.A.; Kent, H.; Costa, J.; Webber, B.L.; Young, R.; Chabner, B.; Baker, A.R.; Brennan, M.F.; Chretien, P.B.; Cohen, M.H.; deMoss, E.V.; Sears, H.F.; Seipp, C.; Simon, R. 1978: Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas Surgery 84(1): 62-69
Lemekhov, V.G.; Barchuk, A.S.; Pinaev, R.N. 2007: Evaluation of efficacy of surgery for early lung cancer Voprosy Onkologii 53(3): 291-294
Zhyl'chuk, V.I.; Alistratov, O.V.; Vorontsova, A.L. 1998: The evaluation of the efficacy of adjuvant laferon therapy in the combined treatment of patients with ovarian cancer based on the monitoring of the tumor marker Ca-125 in the blood serum Likars'ka Sprava 2: 137-139
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Ferraldeschi, R.; D'Auria, G.; Ceratti, A.D.P.; Assalone, P.; Mentuccia, L.; Ciprotti, M.; Evangelista, M.L.; Mazzoli, M.; Di Fonzo, C.; Cortesi, E. 2004: Induction therapy before surgery for non-small cell lung cancer Rays 29(4): 445-452
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456